A 45-year-old woman is evaluated in the surgical clinic for a rapidly enlarging mass in her right breast. She first noticed a small lump approximately 4 months ago, but it has doubled in size over the past 4 weeks. She reports no pain, fever, or nipple discharge. Her medical history is unremarkable, and she takes no medications. On physical examination, the breasts appear asymmetric. A 7-cm, firm, smooth, and mobile mass is palpable in the upper half of the right breast. The overlying skin is stretched and shiny with prominent superficial veins, but there is no erythema, dimpling, or nipple retraction. No axillary or supraclavicular lymphadenopathy is appreciated. Breast ultrasonography demonstrates a large, solid, hypoechoic mass with internal cleft-like cystic spaces. A subsequent core needle biopsy reveals a biphasic proliferation consisting of benign epithelial elements and a hypercellular stroma with leaf-like architectural patterns. There are 6 mitoses per 10 high-power fields and moderate stromal atypia. Which of the following is the most appropriate next step in the management of this patient?
- AEstrogen receptor testing followed by initiation of endocrine therapy
- BObservation with repeat clinical examination and ultrasonography in 3 months
- Surgical removal of the mass with at least 1-cm tumor-free marginsAnswer
- DTotal mastectomy combined with sentinel lymph node evaluation
- EAdministration of neoadjuvant doxorubicin-based chemotherapy